COMMUNIQUÉS West-GlobeNewswire

-
Neos Therapeutics Announces Proposed Offering of Common Stock
05/11/2018 -
Dynavax Reports Third Quarter 2018 Financial Results, Progress on HEPLISAV-B Launch, and Updated SD-101 Data in Three Patient Populations
05/11/2018 -
REVA Medical Reports Third Quarter 2018 Financial Results
05/11/2018 -
Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018
05/11/2018 -
Novo Nordisk A/S - Share repurchase programme
05/11/2018 -
Novo Nordisk A/S purchases B shares worth DKK 1,262 million from Novo Holdings A/S under the 2018 share repurchase programme
05/11/2018 -
FDA Approves Lixte Biotechnology’s IND to Conduct a Phase 1b/2 Trial of LB-100 in Patients with Myelodysplastic Syndrome at Moffitt Cancer Center
05/11/2018 -
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
05/11/2018 -
VALNEVA : Déclaration d'actions et de droits de vote - OCTOBRE 2018
05/11/2018 -
Sanofi: Disclosure of trading in own shares
05/11/2018 -
Sanofi : Déclaration des transactions sur actions propres
05/11/2018 -
Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2018
05/11/2018 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 octobre 2018
05/11/2018 -
Nicox: Number of voting rights as of October 31.2 018
05/11/2018 -
Nicox : Nombre de droits de vote au 31 octobre 2018
05/11/2018 -
Ossur Hf : Transactions in relation to share buyback program
05/11/2018 -
Tabula Rasa Healthcare Announces Time Change for Release of Third Quarter 2018 Operating Results and Conference Call
05/11/2018 -
The Delta Companies Is Recertified by The Joint Commission
05/11/2018 -
RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD
05/11/2018
Pages